FDA recall record

Arizona Beverages USA Net Wt recall — FDA F-1466-2013

Undeclared Splenda ingredient.

Class IIIclassification
F-1466-2013official record ID
Jun 12, 2013report date

Recall record at a glance

Official recordF-1466-2013
CategoryFood Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmArizona Beverages USA LLC
Report dateJun 12, 2013
Recall initiation dateMay 15, 2013
Quantity10,286 cases (4 containers per case)
LocationWoodbury, NY, United States

Official product description

ORIGINAL BRAND Arizona SOUTHERN STYLE UNSWEETENED Brewed Tea, Net Wt. 128 FL.OZ (1 GAL.). Product is packaged in a cardboard case, each case contains four 1 Gallon plastic containers. UPC Code: 6 1300871981 4.

Why the product was recalled

Undeclared Splenda ingredient.

Distribution information

CT, PA, NY, NJ, MI, IL and WI.

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: E-Mail.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.